CDK2-IN-7

• UNSPSC Description:

  CDK2-IN-7 is a CDK2 inhibitor for researching cancer (IC50 < 50 nM).

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk2-in-7.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1C2(CC2)C3=CN=C(NC4=CC=C(C=C4)S(NC5(CNC5)C)(=O)=O)N=C3N1[C@@]6([H])[C@@](O)(CCC6)C

• Molecular Weight:

  498.60

• References & Citations:

  [1]Sabnis RW. Sulfonylamide Compounds as CDK2 Inhibitors for Treating Cancer. ACS Med Chem Lett. 2021 Sep 13;12(10):1528-1529.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2498658-13-0